These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 12871854)
81. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells. Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970 [TBL] [Abstract][Full Text] [Related]
82. Bronchoalveolar lavage surfactant protein a, B, and d concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. Beresford MW; Shaw NJ Pediatr Res; 2003 Apr; 53(4):663-70. PubMed ID: 12612206 [TBL] [Abstract][Full Text] [Related]
83. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Honda Y; Takahashi H; Shijubo N; Kuroki Y; Akino T Chest; 1993 Feb; 103(2):496-9. PubMed ID: 8432143 [TBL] [Abstract][Full Text] [Related]
84. Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D. Parsons LM; Zoueva O; Grubbs G; Plant E; Jankowska E; Xie Y; Song H; Gao GF; Ye Z; Khurana S; Cipollo JF Front Mol Biosci; 2023; 10():1207670. PubMed ID: 37383151 [TBL] [Abstract][Full Text] [Related]
85. Elucidating the enhanced binding affinity of a double mutant SP-D with trimannose on the influenza A virus using molecular dynamics. Li D; Minkara MS Comput Struct Biotechnol J; 2022; 20():4984-5000. PubMed ID: 36097510 [TBL] [Abstract][Full Text] [Related]
86. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. White MR; Crouch E; van Eijk M; Hartshorn M; Pemberton L; Tornoe I; Holmskov U; Hartshorn KL Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L831-40. PubMed ID: 15608147 [TBL] [Abstract][Full Text] [Related]
87. Genomic analysis of conjugative and chromosomally integrated mobile genetic elements in oral streptococci. Lee E; Priutt E; Woods S; Quick A; King S; McLellan LK; Shields RC Appl Environ Microbiol; 2024 Oct; 90(10):e0136024. PubMed ID: 39254330 [TBL] [Abstract][Full Text] [Related]
88. Protein-bound sialic acid in saliva contributes directly to salivary anti-influenza virus activity. Kobayashi K; Shono C; Mori T; Kitazawa H; Ota N; Kurebayashi Y; Suzuki T Sci Rep; 2022 Apr; 12(1):6636. PubMed ID: 35459785 [TBL] [Abstract][Full Text] [Related]
89. Exosome therapeutics for COVID-19 and respiratory viruses. Popowski KD; Dinh PC; George A; Lutz H; Cheng K View (Beijing); 2021 Jun; 2(3):20200186. PubMed ID: 34766162 [TBL] [Abstract][Full Text] [Related]
90. Glycosylation and Aging. Cindrić A; Krištić J; Martinić Kavur M; Pezer M Adv Exp Med Biol; 2021; 1325():341-373. PubMed ID: 34495544 [TBL] [Abstract][Full Text] [Related]
91. Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19. Hartshorn KL Front Cell Infect Microbiol; 2020; 10():563850. PubMed ID: 33194802 [TBL] [Abstract][Full Text] [Related]
92. Structures of SALSA/DMBT1 SRCR domains reveal the conserved ligand-binding mechanism of the ancient SRCR fold. Reichhardt MP; Loimaranta V; Lea SM; Johnson S Life Sci Alliance; 2020 Apr; 3(4):. PubMed ID: 32098784 [TBL] [Abstract][Full Text] [Related]
93. Inhibition of Influenza A Virus by Human Infant Saliva. Gilbertson B; Edenborough K; McVernon J; Brown LE Viruses; 2019 Aug; 11(8):. PubMed ID: 31434247 [TBL] [Abstract][Full Text] [Related]
94. The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus. Hsieh IN; De Luna X; White MR; Hartshorn KL Front Immunol; 2018; 9():1368. PubMed ID: 29951070 [TBL] [Abstract][Full Text] [Related]
95. Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus. van Eijk M; Rynkiewicz MJ; Khatri K; Leymarie N; Zaia J; White MR; Hartshorn KL; Cafarella TR; van Die I; Hessing M; Seaton BA; Haagsman HP J Biol Chem; 2018 Jul; 293(27):10646-10662. PubMed ID: 29769321 [TBL] [Abstract][Full Text] [Related]
96. Microparticle and anti-influenza activity in human respiratory secretion. Suptawiwat O; Ruangrung K; Boonarkart C; Puthavathana P; Maneechotesuwan K; Charngkaew K; Chomanee N; Auewarakul P PLoS One; 2017; 12(8):e0183717. PubMed ID: 28832645 [TBL] [Abstract][Full Text] [Related]
97. Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection. Ivinson K; Deliyannis G; McNabb L; Grollo L; Gilbertson B; Jackson D; Brown LE J Virol; 2017 Jul; 91(14):. PubMed ID: 28446669 [TBL] [Abstract][Full Text] [Related]
98. Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity. Gilbertson B; Ng WC; Crawford S; McKimm-Breschkin JL; Brown LE J Virol; 2017 Jul; 91(14):. PubMed ID: 28446666 [TBL] [Abstract][Full Text] [Related]
99. The scavenging capacity of DMBT1 is impaired by germline deletions. Bikker FJ; End C; Ligtenberg AJM; Blaich S; Lyer S; Renner M; Wittig R; Nazmi K; van Nieuw Amerongen A; Poustka A; Veerman ECI; Mollenhauer J Immunogenetics; 2017 Jun; 69(6):401-407. PubMed ID: 28364129 [TBL] [Abstract][Full Text] [Related]
100. SALSA: A Regulator of the Early Steps of Complement Activation on Mucosal Surfaces. Reichhardt MP; Meri S Front Immunol; 2016; 7():85. PubMed ID: 27014265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]